More studies are needed to verify the consistency of the expression of other potential markers such as IDO1, LAG-3/GAL3 and H7-B3 ICs in PCa to determine whether they could qualify as additional markers for metastasised PCa-targeted and personalising therapeutic approach. Here, LAG3 is linked to posterior cortical atrophy.